Anika Therapeutics (NASDAQ:ANIK) Upgraded to Buy at StockNews.com
StockNews.com upgraded shares of Anika Therapeutics (NASDAQ:ANIK – Free Report) from a hold rating to a buy rating in a research note published on Thursday morning. Separately, Barrington Research lowered their target price on shares of Anika Therapeutics from $25.00 to $20.00 and set an “outperform” rating on the stock in a report on Thursday. […]
StockNews.com upgraded shares of Anika Therapeutics (NASDAQ:ANIK – Free Report) from a hold rating to a buy rating in a research note published on Thursday morning. Separately, Barrington Research lowered their target price on shares of Anika Therapeutics from $25.00 to $20.00 and set an “outperform” rating on the stock in a report on Thursday. […]
